Increased transgene expression mediated by recombinant adeno-associated virus in human neuroglia cells under microgravity conditions by Sun, Feiyi et al.
The space environment has the special characteristics 
of radiation, noise particularity and weightlessness, all 
of which have adverse effects on astronauts’ muscles, 
bones, neurons and immune system. Some reports 
have shown that chemotherapy and radiotherapy can 
increase the activity of the recombinant adeno-
associated virus (AAV) which is widely used in gene 
therapy. In this paper, recombinant AAV2 (rAAV2) 
was first packaged with the enhanced green fluores-
cence protein (eGFP) gene and used to infect neuroglia 
cells including the U87 and U251 cell lines, under mi-
crogravity conditions; it was then detected by fluores-
cence microscopy and flow cytometry. The results 
show that microgravity affects the adhesion ability of 
cells, promotes transgene expression induced by 
rAAV2 and causes changes of viral infection receptors 
at different time points. These findings broaden the 
current understanding of the microgravity effects on 
rAAV, with significant implications in gene therapy 
and the mechanisms of increased virus pathogenicity 
under space microgravity. 
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associated virus in human neuroglia cells under microgravity conditions 
Introduction 
 
Microgravity, which is gravity or other forces caused 
by acceleration, is no more than 10-5 ~ 10-4g. Due to 
the balance between the centrifugal force and gravity, 
objects inside the orbiting spacecraft are in a close-to-
zero gravity state, so the space environment is a micro-
gravity environment. The space environment with the 
particularity of weightlessness has negative effects on 
the astronauts’ muscles (Gopalakrishnan et al. 2010, 
Tesch et al. 2005), cardiovascular function (Platts et 
al. 2006, Stenger et al. 2010), metabolism (Morgan et 
al. 2012, Zwart et al. 2010), bones (Keyak et al. 2009, 
Smith et al. 2014), sensory (Lowrey et al. 2014) and 
immune systems (Crucian et al. 2009, Hughes-Fulford 
et al. 2015). Similarly, there is evidence showing that 
microgravity enhances the bacterial pathogenicity of 
salmonella typhimurium (Chopra et al. 2006, Nicker-
son et al. 2000) and the reactivation of latent virus in-
fections, such as Epstein-Barr virus (Sonnenfeld & 
Shearer 2002, Stowe et al. 2001) as well as herpes 
simplex virus type 1 (Fuse & Sato 2004), but the 
mechanisms behind this are not well understood. In 
this experiment, the microgravity effects on the virus 
was studied via simulating a weightless environment. 
This can be achieved in multiple ways including drop-
towers, parabolic flights of airplanes, sounding rockets 
or orbiting space platforms (Kiss 2014). In this study, a 
biaxial clinostat device, which can simulate the effect 
of microgravity on biology on the ground, was used to 
study the biological changes. The device consists of 
two independent rotating frames (outer and internal 
frame), a driving device, a bracket base and a control-
ler, and is similar to a 3D gyrator (Hoson et al. 1992). 
The adeno-associated virus (AAV) is a common 
non-pathogenic parvovirus which was discovered as a 
contamination in the preparation of adenovirus in 1965
(Atchison et al. 1965, Smith 2008). AAV is a single 
linear DNA virus with an icosahedron capsid but no 
envelope. Its diameter is about 20 nm, which makes 
AAV the smallest animal DNA virus. It is the only 
known virus which can integrate into mammalian 
DNA with two open reading frames (ORF) and in-
verted terminal repeats (ITR) (King et al. 2001). Re-
combinant adeno-associated virus (rAAV) is derived 
from wild type AAV by reserving the long terminal 
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repeat (LTR) and inserting an exogenous recombinant 
promoter region and the specific gene sequence which 
replaces the genome of AAV itself.  
Gene therapy based on rAAV vectors holds 
promising potential in oral medication because of its 
good thermal stability and resistance to acid and alkali 
(pH 3.0-9.0), as well as the treatment of organic sol-
vent resistance characteristics (Ma et al. 2005, Santi-
ago-Ortiz & Schaffer 2016). The first human gene 
therapy using rAAV vectors was performed in cystic 
fibrosis (CF) patients (Loring et al. 2016) and the heal-
ing of rheumatoid arthritis and osteoarthritis (OA) us-
ing rAAV offered promise for further clinical testing 
(Madry & Cucchiarini 2016, Zhou et al. 2016). Be-
cause of the particular structure and location of the 
brain, rAAV-mediated gene therapy is considered dif-
ficult, but some recent studies have shown that AAV 
can associate with exosomes (exo-AAV) when the 
vector is isolated from the conditioned media of pro-
ducer cells. In this case, it is more resistant to neutral-
izing anti-AAV antibodies and more efficient at brain-
targeted gene delivery while it has also been reported 
to mediate brain-derived neurotrophic factor (BDNF) 
expression in the rat striatum (Connor et al. 2016, 
Hudry et al. 2016). In this experiment, rAAV was cho-
sen because of its non-pathogenic and universality in 
the human body under normal gravity. 
At present, 12 kinds of AAV serotypes were rec-
ognized by the International Committee on Taxonomy 
of viruses (Wu et al. 2006, Schmidt et al. 2008). These 
subtypes are mainly based on human and primate ani-
mal hosts; AAV1 - 6 is obtained from human tissue. 
Among AAV1-6, AAV2 is the earliest and most 
widely used serotype of infectious clones, because it 
has the widest tissue targeting abilities, including neu-
rons, liver, skeletal muscle, retina and heart (Bartlett et 
al. 1998, Manno et al. 2003, 2006, Salva et al. 2007). 
Concerning the virus binding cell surface receptor, in 
the case of AAV1, AAV5 and AAV6, this receptor is 
N-linked sialic acid. The major cell surface receptor of 
AAV2 and AAV3 is heparan sulfate proteoglycans 
(HSPG), which is encoded by the heparan sulfate pro-
teoglycan gene. It is a composite macromolecule con-
sisting of a nuclear protein molecule and one or more 
glycosaminoglycans connected by glucosidic bonds. It 
is widely spread among mammalian cell surfaces in-
cluding the cell base membrane (BM) and extracellular 
matrix (ECM) (Bishop et al. 2007). The cell surface 
receptor of AAV4 is O-linked sialic acid, the one of 
AAV8 is the laminin receptor (LamR) while the cell 
surface receptors of AAV7 and AAV9 - 12 are not 
clear at present (Summerford et al. 1998, 1999, Qing 
et al. 1999). The initial stage of viral infection is the 
viral attachment protein adsorbed to the cell surface. 
HSPG, as the major initial binding receptor, plays an 
important role in the attachment process of the AAV2 
infection (Bishop et al. 2007). Integrin αvβ5 and fibro-
blast growth factor receptor 1(FGFR-1) are accessory 
receptors, and can enable AAV2 to attach and enter the 
cells through endocytosis mediated receptors (Bartlett 
et al. 1998, Perabo et al. 2006, Qing et al. 1999, Sum-
merford et al. 1998, 1999). 
 The present study aimed to evaluate how 
rAAV2 responds when transfecting the human neuro-
glia cell line U87 or U251 and investigate the changes 
of rAAV pathogenicity or latency in weightlessness or 
microgravity conditions. The U87 and U251 cell lines, 
which were firstly transfected with rAAV2 encoding 
eGFP, were cultured under microgravity as well as 
normal gravity conditions to study the changes of the 
rAAV2 infection ability and cellular morphology. Af-
ter different post-treatment time points, the infection 
efficiency and the transcriptional level of various viral 
receptors including HSPG, FGFR1 and Integrin αvβ5 
were detected, in order to investigate the effect of mi-
crogravity on transgene expression, rAAV2 infection 
and the changes of viral infection receptors on cells. 
 
Materials and Methods 
 
Cell culture 
U87 or U251 were cultured in DMEM (HyClone, 
USA) supplemented with 10% FBS, 1% NEAA and 
antibiotics (100 units/ml penicillin and 100μg/ml strep-
tomycin, Beijing Solarbio company, China) at 37 °C in 
5% CO2. Cells were passaged when 80% confluent. 
Cells were transferred into 5 culture bottles before the 
experiment, one for cell counting and the others for 
transfection by rAAV2 encoding the eGFP gene. 
 
RAAV2 preparation and transfection 
The packaging of rAAV2, including the shuttle plas-
mid carrying the eGFP gene is referenced in a previous 
report (Ma et al. 2005). The transfection plasmid was 
extracted according to the plasmid extraction kit of the 
manufacturer's protocol (Tiangen biotech, Co. Ltd, 
Beijing, China). RAAV2 virus packaging used the cal-
cium phosphate transfection method, according to the 
"AdEasy Vector System" operation protocol. HEK293 
cells which were used in rAAV2 packaging were ob-
tained by the University of British Columbia, Canada. 
HEK293 cells were cultured in DMEM supplemented 
with 10% FBS and antibiotics (100 units/mL penicillin 
and 100 μg/mL streptomycin) at 37 °C in 5% CO2. 4 
hours before packaging, the culture medium was re-
placed with 5 mL of fresh medium without antibiotics 
and the cell confluence was lower than 50%. The 
transfection plasmids were then added. After 2 days, 
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cells were collected and centrifuged at 1500 rpm for 5 
min. The heparin column (GE company, USA) was 
then used to purify the packaged rAAV. The resulting 
concentration of the virus was about 1012Gps/mL, ob-
tained by absolute quantitative PCR analysis. 
 
RAAV2 infection and cell culture under micrograv-
ity 
RAAV2 was diluted with pure DMEM according to 
the multiplicity of infection (MOI), which refers to the 
number of virus particles per cell. When the viruses 
were used to infect cells, the following calculation for-
mula was used: rAAV2 volume = the number of cells 
× MOI / virus titer. The rAAV2 dilution was then 
added into 2 of the 4 bottles and cells were cultured at 
37 °C in 5% CO2 for 1 hour, while the rest were cul-
tured with pure DMEM. 
 After infection, the 4 bottles were filled up 
with complete culture medium; one rAAV2-infected 
bottle and one non-rAAV2-infected bottle was then 
placed into the biaxial clinostat device (developed by 
the Academy of Sciences Chinese space science and 
Applied Research Center). The other 2 bottles were 
placed in the normal cell culture incubator, all at 37 °C 
in 5% CO2 atmosphere for three different time periods 
(24h, 48h and 72h). Cells were collected and analysed 
by flow cytometry (FACS420 Becton, USA) and a 
fluorescent inverted microscope (IX71, Olympus). 
 
Real time quantitative polymerase chain reaction 
(RT-qPCR) 
U87 or U251 cells were removed from the culture bot-
tles by trypsinisation, following microgravity and nor-
mal gravity culture, at 24h, 48h and 72h. and were col-
lected for RNA isolation and subsequent RT-qPCR 
analysis. Duplicate RT reactions (RT replicates) were 
performed for each RNA sample. RT controls were 
created from pooled samples of RNA, without reverse 
transcriptase or control DNA contamination of RNA. 
All complementary DNA (cDNA) samples were stored 
at -20 °C prior to analysis. The TransStart Top Green 
qPCR SuperMix kit (TransGen Biotech) was used for 
all qPCR reactions according to the manufacturer's 
protocol. The Applied BioRad iQ5 Real Time PCR 
system was used. The cycle threshold (CT) values 
were collected and the fold increase was calculated as 
following: 
n-fold increase due to treatment = 
2(- (CTgene of interest
-CT
GADPH
) sampleA-(CT
gene of interest
-CT
GADPH
) 
sampleB) 
The reaction of each primer pair (GADPH, HSPG, 
FGFR1, WPRE and Integrin αvβ5) is shown in Table 
1; three PCR replicates were analyzed for each cDNA 
replicate. The primers were designed with Primer3 
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Figure 1. Comparison of the efficiency of rAAV2 infection of U87 and U251 cells at 24h, 48h, 72h in different conditions. A, 
D, G: The fluorescence field of U87 infected by rAAV2 in normal gravity; B, E, H: The fluorescence field of infected U87 
with microgravity simulated simultaneously; C, F, I: The fluorescence field of U87 infected for 6 h first and then simulated 
microgravity; J, M, P: The fluorescence field of U251 infected by rAAV2 in normal gravity; K, N, Q: The fluorescence field of 
infected U251 with microgravity simulated simultaneously; L, O, R: The fluorescence field of U251 infected for 6 h first and 
then simulated microgravity (Scale bar=100μm). 
24h 
48h 
72h 
U87 U251 
(http://frodo.wi.mit.edu/primer3/input.htm). 
 
Statistical analysis 
Unless mentioned, the results are presented as 
mean ± SD of three independent experiments. Statisti-
cal analysis was performed by two-tailed t test by Ex-
cel and Origin 8 software. A p value < 0.05 was con-
sidered significant unless mentioned otherwise. 
 
Results 
 
Microgravity promotes the transduction of rAAV2 
into neuroglia cells 
To explore the relation between microgravity and 
rAAV2, U87 and U251 were both infected under two 
different treatments: either cells were infected for 6h 
and then went through simulated microgravity or cells 
were infected and went through simulated micrograv-
ity simultaneously via the biaxial rotary device. The 
cells were then detected at 24h, 48h and 72h via fluo-
rescent inverted microscopy (Figure 1). The fluores-
cence intensity of both U87 and U251 gradually in-
creased with time, and the weakest fluorescence inten-
sity of U87 and U251 both appeared at 24h, while the 
strongest one was at 72h. These results show that there 
is a similar gradual increase in the transgene expres-
sion of rAAV2 in U87 and U251 with time, whether 
cultured through simulated microgravity (Figure 1B, 
C, E, F, H, I, K, L, N, O, Q, R) or normal gravity 
(Figure 1A, D, G, J, M, P). Interestingly, the magni-
tude of rAAV2 expression in microgravity was signifi-
cantly higher than that in normal gravity. This suggests 
that microgravity might promote gene expression me-
diated by rAAV2 in neuroglia cells or the infection 
capacity of rAAV2. Meanwhile, there was no obvious 
difference between the fluorescence field of U87 and 
U251 cells that were infected and went through simu-
lated microgravity simultaneously (Figure 1B, E, H, K, 
N, Q) and the ones that were infected for 6h first and 
then went through simulated microgravity (Figure 1C, 
F, I, L, O, R). This suggests that microgravity has no 
obvious effect on the infection capacity of rAAV2 and 
the difference between the microgravity and the nor-
mal gravity group is mainly caused by the improve-
ment of gene expression mediated by rAAV2 within 
cells. Furthermore, the infection efficiency of rAAV2 
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Figure 2. FACS analysis of transduction efficiency of rAAV2 in U87 and U251 cells collected 72 h post-infection. A: U87 
cultured in normal gravity; B: U87 cultured in microgravity; C: U87 infected by rAAV2 in normal gravity; D: U87 infected for 
6 h first and then simulated microgravity; E: U87 infected and simulated microgravity simultaneously; F: U251 cultured in 
normal gravity; G: U251 cultured in microgravity; H: U251 infected by rAAV2 in normal gravity; I: U251 infected for 6 h first 
and then simulated microgravity; J: U251 infected and simulated microgravity simultaneously. There were no positive cells in 
A, B, F and G compared to the others that showed different positive cell numbers. 
U87 
U251 
A B C D E 
F G H I J 
Primer Sequence (5'-3') 
GADPH F ACAACTTTGGTATCGTGGAAGG 
GADPH R GCCATCACGCCACAGTTTC 
eGFP F CAAGATCCGCCACAACATCG 
eGFP R GACTGGGTGCTCAGGTAGTG 
HSPG F CATGGGCTGAGGGCATACG 
HSPG R TGTGCCCAGGCGTCGGAAC 
FGFR1 F TGGAGTTCATGTGTAAGG 
FGFR1 R TCAAGATCTGGACATAAGG 
Integrin αvβ5 F CAAGAGCCGGATAGAGGACA 
Integrin αvβ5 R GTTCTGCTCCCCAAACACTT 
WPRE F TGGCGTGGTGTGCACTGT 
WPRE R AAAGGAGCTGACAGGTGGTG 
Table 1. List of primers used for the different genes. F, for-
ward; R, reverse. 
 
in U87 was higher than that in U251 cells, and the 
transgene expression of rAAV2 in U87 and U251 
gradually increased with time and was higher under 
microgravity compared to normal gravity conditions. 
 To quantify the transduction of rAAV2 in dif-
ferent gravity conditions, the virus infection rate of 
U87 and U251 was detected by flow cytometry 
(FACS420 Becton, USA) at 72h after rAAV2-eGFP 
infection (Figure 2). According to the flow cytometry 
results, when U87 and U251 cultured in the normal 
gravity group were set as their own control group, U87 
and U251 positive cells, infected by rAAV2, ac-
counted for 32.4% and 33.4% of the total cells (Figure 
2C and H). This was significantly lower compared to 
that of U87 and U251 cells that were infected for 6h 
first and then went through simulated microgravity 
(71.0% and 57.8% respectively) (Figure 2D and I). 
The U87 and U251 positive cells that were infected 
and went through simulated microgravity simultane-
ously accounted for 59.3% and 58.8% of the total 
cells, respectively. (Figure 2E and J). These results 
might prove that microgravity does have a certain ef-
fect on virus infected cells. Furthermore, the results of 
U87 and U251 infected for 6h first and then simulated 
microgravity group and the results of U87 and U251 
infected and simulated microgravity simultaneously 
group were similar, i.e. the proportions of positive 
cells over total cells were similar, which suggests that 
the enhancement effect of microgravity on rAAV2 en-
tering the cell is not obvious. The data above shows 
infected U87 and U251 cells have an obvious improve-
ment under microgravity and no significant difference 
between simulated microgravity simultaneously and 6h 
later. 
 
Microgravity promotes the transgene expression 
mediated by rAAV2 in neuroglia cells 
In order to quantify the expression of rAAV2 in cells 
under microgravity, the fluorescence intensity of U87 
and U251 cell line expressing eGFP was detected via 
flow-cytometric analysis, while U87 was chosen to 
quantify the expression level of eGFP gene for further 
confirmation of the effect of microgravity on expres-
sion of rAAV2 at the molecular level. The average 
fluorescence intensity of U87 and U251 positive cells 
in the microgravity group was significantly higher 
compared to the normal gravity group (Figure 3A and 
B), which showed that microgravity might have an 
enhancing effect on the transgene expression mediated 
by rAAV2 in cells. Similarly, the expression level of 
eGFP gene in U87 cells that were infected by rAAV2 
and went through microgravity conditions simultane-
ously was significantly higher compared to the normal 
gravity group at 24h, 48h and 72h, and was detected 
via a real-time fluorescent quantitative PCR instrument 
(Figure 4C). The proportion of U87 infected by 
rAAV2 and simulated microgravity simultaneously 
group over U87 infected by rAAV2 in normal gravity 
group was growing from 24h to 72h, and the propor-
tion was highest at 48h (Figure 4D). This indicates that 
the fluorescence intensity of U87 infected by rAAV2 
significantly increased under microgravity with time, 
and the efficiency of gene expression was enhanced 
under microgravity but decreased slightly at 72h be-
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Figure 3. Analysis of average fluorescence intensity of U87 and U251 cells collected 72 h post-infection. A) The fluorescence 
intensity of U87 cells expressing eGFP. A: U87 cultured in normal gravity; B: U87 cultured in microgravity; C: U87 infected 
by rAAV2 in normal gravity; D: U87 infected for 6 h first and then simulated microgravity; E: U87 infected and simulated 
microgravity simultaneously. B) The fluorescence intensity of U251 cells expressing eGFP. F: U251 cultured in normal grav-
ity; G: U251 cultured in microgravity; H: U251 infected by rAAV2 in normal gravity; I: U251 infected for 6 h first and then 
simulated microgravity; J: U251 infected and simulated microgravity simultaneously. Values are means ± SD (n = 3). **P < 
0.01 compared with cells infected rAAV2 in normal gravity, ***p < 0.001 compared with cells infected rAAV2 in normal 
gravity, two tail t test. 
(B) (A) 
cause of changes in the cell death rate. All data sug-
gests that microgravity could induce a significant tran-
scriptional improvement after rAAV2 infection in neu-
roglia cells. 
 
Microgravity affects the adhesion ability of neuro-
glia cells 
To explore the effect of microgravity on the cell adhe-
sion ability, U87 and U251 cells were cultured under 
normal gravity and microgravity conditions (Figure 5). 
Results show that all cells have a small number of sus-
pension cells under microgravity, no matter whether 
cells were infected by rAAV2 or not (Figure 5A, B and 
C, D and E, F and G, H). Especially, U87 suspension 
cells were significantly more than U251 cells, and a 
portion of U87 cells actually adhered to the culture 
dishes with no pseudopodium and became circular 
while they also clustered into clusters (Figure 5B, D 
and F, H). The image mentioned above shows that U87 
is more sensitive to microgravity and whether cells 
were infected by rAAV2 or not, there is no obvious 
effect on cell morphology. These suggest that micro-
gravity affects the cell adhesion ability and U87 was 
selected to further study the effect of microgravity. 
 
Microgravity and normal gravity induce different 
changes on virus receptors  
To further investigate the molecular mechanism of mi-
crogravity on transgene expression induced by rAAV2, 
U87 cells were chosen because these cells, under mi-
crogravity, show sensitive changes in their form and in 
response to rAAV2 infection. The transcriptional ex-
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Figure 4. Effect of microgravity on the transcriptional level of transgene expression mediated by rAAV2-eGFP.A) Black bar 
shows U87 infected by rAAV2 and simulated microgravity simultaneously group; white bar showing U87 infected by rAAV2 
in normal gravity group. B) Pattern bar showing the proportion between U87 infected by rAAV2 in microgravity simultane-
ously group and normal gravity group. Values are means ± SD (n = 3). *P < 0.05 compared with white bar, ***p < 0.001 com-
pared with white bar at same point or between pattern bar at different point, two tail t test. 
(A) (B) 
U87 
U251 
Figure 5. Effect of microgravity on the cell adhesion ability at 48h after rAAV2-eGFP infection. A: U87 cultured in normal 
gravity; B: U87 cultured in microgravity; C: Infected U87 cultured in normal gravity; D: Infected U87 cultured in micrograv-
ity; E: U251 cultured in normal gravity; F: U251 cultured in microgravity; G: Infected U251 cultured in normal gravity; H: 
Infected U251 cultured in microgravity (Scale bar=100μm). 
pression of virus receptors in infected cells was de-
tected via real-time fluorescent quantitative PCR at 24, 
48 and 72h (Figure 6). We analyzed the changes of 
HSPG, FGFR1 and Integrin αvβ5 virus receptors under 
microgravity.  
 Firstly, HSPG, as the initial binding receptor 
which has a major effect on the process of infection, 
was at an obviously higher level at 24h, 48h and 72h in 
U87 infected by rAAV2 under simulated microgravity 
simultaneously compared with U87 infected by 
rAAV2 in the normal gravity group (Figure 6A). This 
result shows that the HSPG receptor plays an impor-
tant role in the expression of rAAV2 in cells and mi-
crogravity makes U87 cells become more sensitive to 
rAAV2 infection. Interestingly, the other virus recep-
tors had different performances at distinct time points. 
The FGFR1 receptor, as a co-receptor for entering into 
cells, in addition to using the cell surface HSPG for 
attachment, had no obvious difference between the 
microgravity and normal gravity condition, although 
the expression level of FGFR1 under microgravity was 
lower than under normal gravity at 24h. However, the 
expression level of FGFR1 receptor under micrograv-
ity was significantly lower than under normal gravity 
at 48h and the difference disappeared at 72h (Figure 
6B). Similarly, the expression level of Integrin αvβ5 
receptor, which is co-activated with FGFR1, HSPG 
during mediated endocytosis of rAAV2 into cells, un-
der microgravity conditions was significantly higher 
than under normal gravity at 24h. However, it had no 
obvious difference between microgravity and normal 
gravity condition subsequently at 48h and 72h (Figure 
6C).  
 These might show that microgravity had vari-
ous effects on different viral receptors respectively, but 
the change of HSPG receptor expression levels be-
tween microgravity and normal gravity was consistent 
at various time points, which suggests that HSPG 
might be a key to cells affected by microgravity. 
 
Discussion 
 
To investigate the effect of microgravity on the expres-
sion and infection mediated by rAAV2 on neuroglia 
cells, the rAAV2-eGFP gene delivery system was used 
to infect the U87 and U251 cell lines, which are of 
glioblastoma origin, under microgravity and normal 
gravity conditions. The results show that microgravity 
could change the adhesion ability of cells and promote 
the expression of rAAV2 (Figure 3, 4, 5), and suggests 
that it plays an important role on the expression and 
infection of rAAV2. On the other hand, the changes of 
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Figure 6. The effect of microgravity on expression of 
rAAV2 receptors. A) The expression level of HSPG receptor 
at 24, 48 and 72h. B) The expression level of FGFR1 recep-
tor at 24, 48, 72h. C) The expression level of Integrin αvβ5 
receptor at 24, 48, 72h. Black bar: U87 infected by rAAV2 
and simulated microgravity simultaneously group; White 
bar: U87 infected by rAAV2 in normal gravity group, Re-
sults represent mean ± SD of 3 independent experiments. *p 
< 0.05, compare between black bar and white bar at same 
time point. **p < 0.01 compare between black bar and white 
bar at same point, two tail t test. 
various virus receptors were detected by fluorescent 
quantitative PCR (Figure 6), which might show that 
microgravity has various effects on these receptors. 
 Adeno-associated virus (AAV) is a replication
-defective DNA virus with relatively low host immune 
response, weak toxicity, and long term gene expres-
sion. In addition, AAV can integrate into the specific 
site of human chromosome 19, AAVS1 site (Flotte 
2004, Russell 2009), and this avoids the risk of inser-
tional mutagenesis and the occurrence of tumors 
caused by random integration. As a gene vector, rAAV 
is widely used in gene therapy (Luo et al. 2015, Bon-
ten et al. 2013). In this experiment, U87 and U251 
were infected by rAAV2 under microgravity and nor-
mal gravity and were detected at different time points. 
The results revealed that, even though both U87 and 
U251 are derived from human glioblastoma, there are 
different sensitivities to rAAV2 infection, suggesting 
that even cells from the same origin may have different 
rAAV2 infection sensitivities. These indicate that there 
are different curative effects on the same type of cells 
from the same part of body in gene therapy mediated 
by rAAV2 vectors. 
 There are some reports showing that micro-
gravity can not only induce changes of gene transcrip-
tion and replication levels such as Epstein-Barr virus 
and herpes simplex virus type 1, but also cause some 
immune cells, such as macrophages, T cells, to change 
the regulation of inflammatory cytokine expression 
and cell activation state (Hughes-Fulford et al. 2015, 
Stowe et al. 2011, Wang et al. 2015). Our results indi-
cate that the ability of rAAV2 to infect neuroglia cells 
increased, and the expression level of rAAV2 in neuro-
glia cells significantly increased in the microgravity 
environment. This suggests that microgravity affects 
not only immune cells, but may also have a positive 
effect on rAAV or neuroglia cells, including the capac-
ity of rAAV infection, rAAV gene expression, and the 
affinity of some receptors on the cell or the regulation 
mechanism of virus expression in cells through an un-
known pathway. These factors may lead to different 
performances of rAAV2 in microgravity or normal 
gravity.  
 On one hand, the AAV2 type is common in the 
human body, which has no obvious pathogenicity un-
der normal gravity, though, this kind of change of vi-
rus or cell under microgravity conditions makes AAV 
potentially pathogenic, which may have an effect on 
astronauts in future long-duration missions. On the 
other hand, the microgravity environment can also be 
used to change the state of pathogenic viruses in order 
to reduce or eliminate pathogenic factors, which pro-
vides a new direction for viral vaccine production. Pre-
vious studies have found that rAAV2 has been shown 
to suppress DNA replication and oncogenicity of a 
number of viruses including adenovirus (Casto et al. 
1967), pox virus (Schlehofer et al. 1986) and human 
papillomavirus (HPV) (Meyers et al. 2001). Micro-
gravity can be used to improve the expression of 
rAAV or the factors that lead to the increase of virus 
expression, and can be further studied to provide a new 
breakthrough for AAV vector mediated gene therapy. 
 The stabilization of the cell’s morphological 
structure mainly relies on the cytoskeleton, which is a 
very active system. It can be reconstructed during a 
short time; even under stable conditions, polymers of 
cytoskeleton and free monomers are changing con-
stantly. The original force balance is broken under mi-
crogravity, while the microfilament and microtubule 
polymerization and depolymerization are very sensi-
tive to a change of gravity (Goldstein et al. 1992, Ing-
ber 1999, Philpott et al. 1992). Studies on adherently 
growing human cells exposed to short-term real micro-
gravity conditions during parabolic flights and subse-
quent analysis on earth have provided some evidence 
for cytoskeleton alteration (Grosse et al. 2012, 
Aleshcheva et al. 2015). Furthermore, the cell adhe-
sion ability can be affected to a certain extent under 
microgravity, as the cells cultured under microgravity 
are more likely to remain in a suspended state while 
the cell attachment time is delayed (Sato et al. 2001). 
Given the importance of the cytoskeleton, its changes 
will directly or indirectly participate in or lead to 
changes in the cell cycle, signaling pathways and 
apoptosis response under microgravity. 
 In this experiment, U87 and U251, infected by 
rAAV2 were studied under microgravity at 24h, 48h 
and 72h. The number of U87 circular cells was signifi-
cantly higher than that of U251; however, the circular 
cells are not like suspension cells which move with the 
movement of the liquid medium. Both U87 and U251, 
adhere to the culture dish with no pseudopodium and 
this might relate to the change of cytoskeleton under 
microgravity. It is worth noting that U87 cells clus-
tered into clusters compared with U251 which had no 
significant clustering phenomenon under microgravity. 
The level of gene expression and protein expression 
showed a consistent trend (Fig. 3, 4), meaning that the 
higher the expression of a gene is, the higher the pro-
tein expression. However, taking into account the dif-
ferent results between U87 and U251, infected by 
rAAV2, in microgravity (Fig. 3, 4), the correlation be-
tween stabilization of cell morphological structure, 
rAAV2 infection and rAAV2 expression in cells need 
to be further explored. Given that there is an interac-
tion between glial cells and immune cells in the brain 
(Appel et al. 2010), changes of nerve cell morphology 
and virus susceptibility might offer a new way for fu-
47   Journal of Molecular Biochemistry, 2016 
ture virus mediated neurological disease gene therapy. 
 To further investigate the causes of the af-
fected infection ability of the virus under microgravity, 
HSPG, FGFR1 and Integrin αvβ5 virus receptor were 
chosen in this experiment. The expression level of the 
accessory receptors affects the endocytosis of rAAV2 
entering cells. A real-time tracking experiment of a 
single AAV molecule showed that AAV completely 
entered in 100ms (Seisenberger et al. 2001). This 
shows that HSPG, FGFR1 and Integrin αvβ5 receptor 
play a key role in the process of rAAV2 infection. In 
this experiment, the expression of rAAV2 and virus 
receptors was detected at 24h, 48h and 72h. Our results 
showed that HSPG, the cell surface receptor, main-
tained high activity under microgravity compared with 
HSPG in normal gravity from 24h to 72h; however, 
the other receptors, namely FGFR1 and Integrin αvβ5, 
had different changes at different time points. The ac-
tivity of FGFR1 was lower in microgravity at 24h and 
48h compared to normal gravity, while there was no 
difference between microgravity and normal gravity at 
72h. Similarly, Integrin αvβ5 receptor’s activity was 
higher in microgravity at 24h, but there was no differ-
ence between microgravity and normal gravity at 48h 
and 72h. The different changes of accessory receptors 
(FGFR1, Integrin αvβ5) at 24h and 48h might be 
caused by the fact that cells couldn’t adapt to the mi-
crogravity environment at the early stages. Therefore, 
this maladaptive situation induced a disorder of the 
accessory receptors; however, cells began to adapt to 
the microgravity environment under the extended mi-
crogravity time and the accessory receptors returned to 
normal levels. Interestingly, HSPG made a response in 
the first time when rAAV2 began to infect, although 
cells were not adapted to the microgravity environment 
at the early stages, possibly because HSPG is the main 
initial binding cell surface receptor of rAAV2 that is 
the most sensitive to virus infection. Microgravity 
could further improve the activity of HSPG via some 
pathways we do not know yet. Overall, whether micro-
gravity affect cells themselves or rAAV2 to cause the 
changes on virus receptors needs to be further re-
searched. 
 In conclusion, this study, which used rAAV2 
mediated eGFP gene delivery to infect U87 and U251 
cell line under microgravity and normal gravity condi-
tion has revealed the effect of microgravity on rAAV2 
infection. The results have shown that microgravity 
affects the adhesion ability of cells, promotes the ex-
pression of rAAV2 in cells and causes virus receptors 
to have different changes at 24h, 48h and 72h. These 
findings may broaden our current understanding of 
microgravity effect on the rAAV infection progression, 
as a whole, with significant implications in rAAV me-
diated gene therapy and the mechanism of increased 
virus pathogenicity under space microgravity condi-
tions. 
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